Company profile
SphereBio company profile
SphereBio develops biotech platforms that deliver molecules to cells, training them to generate specific responses to health issues. The company is now using platforms to offer pharmaceutical and veterinary companies a novel approach to potentiate vaccines and therapeutics tailored to specific diseases, such as cancer. It was founded in 2023.
Business identity
- Website
- https://www.spherebio.co
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- Krasnohirka, Kirovohrad, Ukraine
- Country code
- UA
- Continent
- Europe